Drug developer Adamas moves closer to $62 million IPO
March 26, 2014 at 14:40 PM EDT
Adamas Pharmaceuticals Inc. will offer nearly 3.5 million shares at $16 to $18 in an IPO, raising more than $62 million, the company said in a regulatory filing Wednesday...